Trial intelligence / Profile preview

Liposomal Curcumin in High-Protein Supplement for Hemodialysis Patients

NCT06381076Phase 3Completed

Sponsor
University of Florida
Start
Feb 2025
Primary completion
May 2025
Countries
1
01

Overview

A Phase 3 trial of liposomal curcumin in chronic kidney disease (CKD), sponsored by University of Florida. Started Feb 2025; status: completed.

02

Drugs

liposomal curcumin
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT06381076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06381076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call